Font Size: a A A
Keyword [Tyrosine Kinase Inhibitors]
Result: 121 - 140 | Page: 7 of 10
121. MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
122. Combining Thalidomide With EGFR Tyrosine Kinase Inhibitors Synergistically Inhibits NSCLC Cells In Vitro And In Vivo
123. Clinical Study Of "Qing Xuan Fei Re Fa" On The Efficacy Of Skin Rash After Applying EGFR-TKI In Patients With Lung Cancer
124. Biomarkers For In Vitro And In Vivo Detection Of Cardiotoxicity Induced By Sunitinib And Imatinib
125. Design,Synthesis And Biological Evaluation Of Novel C-Met And Multi-target Tyrosine Kinase Inhibitors
126. The Study On TDM Of Tri-azole Antifungal Agents And Tyrosine Kinase Inhibitors And Identification Of Endogenous Keto-steroids In Human Plasma Using LC-MS/MS
127. The Characteristics Of Epidermal Growth Factor Receptor With Rare Mutations In Non-small Cell Lung Cancer And The Effect Of EGFR Tyrosine Kinase Inhibitors On Them
128. Comparative Efficacy Comparison And Prognostic Analysis Of Tyrosine Kinase Inhibitors Combined With Chemotherapy In The Treatment Of Patients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
129. Design,Synthesis And Anti-tumor Activity Study Of Thiazolinone Urea Derivates
130. Discontinuation Of Tyrosine Kinase Inhibitors In Patients With Chronic Myeloid Leukemia:a Meta-Analysis
131. Study On Mutation Profile And Frequency Of EGFR Exon 19 In Chinese Patients With Non-Small Cell Lung Cancer
132. Predictive Value Of Early Molecular Response For Deep Molecular Response In Chronic Phase Of Chronic Myeloid Leukemia
133. Clinical Efficacy Of Third-line Tyrosine Kinase Inhibitors In Advanced Gastrointestinal Stromal Tumors After Failure Of Imatinib And Sunitinib: A Meta-analysis Of Recent Clinical Trials
134. The Research On TKIs-related Adverse Events And Efficacy In Chronic Myeloid Leukemia
135. Study On EGFR-TKIs Resistance And BIN1 Expression In Lung Adenocarcinoma
136. The Effects Of Tyrosine Kinase Inhibitors On Ferritinophagy In Chronic Myeloid Leukemia And The Research On Related Mechanisms
137. Clinical Outcomes Of Surgery Combined With Targeted Therapy In Non-Small Cell Lung Cancer
138. Design,Synthesis And In Vitro Anti-tumor Activity Evaluation Of 4-phenoxyquinoline Derivatives
139. Real-World Evidence Of Molecular Response To Tyrosine Kinase Inhibitors From China
140. Model To Predict PFS Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Chinese Han Lung Adenocarcinoma Population
  <<First  <Prev  Next>  Last>>  Jump to